216 related articles for article (PubMed ID: 23979979)
1. Myeloperoxidase G463A polymorphism and risk of lung cancer.
Li J; Fu Y; Zhao B; Xiao Y; Chen R
Tumour Biol; 2014 Jan; 35(1):821-9. PubMed ID: 23979979
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase G463A polymorphism and lung cancer risk in Asians: a pooled analysis.
Zhou YY; Zhang SM; Cai ZG; Zhang H; Wang L; Xu XP; Wu HB
Tumour Biol; 2013 Oct; 34(5):3035-9. PubMed ID: 23832536
[TBL] [Abstract][Full Text] [Related]
3. Association between MPO 463G>A polymorphism and risk of lung cancer: a meta-analysis.
Zhou C; Luo Q; Qing Y; Lin X; Zhan Y; Ouyang M
Tumour Biol; 2013 Dec; 34(6):3449-55. PubMed ID: 23943394
[TBL] [Abstract][Full Text] [Related]
4. The association between myeloperoxidase 463G>A polymorphisms and risk of lung cancer in East-Asia population.
Hou X; Gao Y; Duan Y; Wang Z; Shi L; Ma J; Xie X
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C97-100. PubMed ID: 26323935
[TBL] [Abstract][Full Text] [Related]
5. The MPO-463G>A polymorphism and lung cancer risk: a meta-analysis based on 22 case-control studies.
Yang JP; Wang WB; Yang XX; Yang L; Ren L; Zhou FX; Hu L; He W; Li BY; Zhu Y; Jiang HG; Zhou YF
PLoS One; 2013; 8(6):e65778. PubMed ID: 23840365
[TBL] [Abstract][Full Text] [Related]
6. Association between myeloperoxidase G-463A polymorphism and lung cancer risk.
Huang C; Ma L; Li D
Tumour Biol; 2014 Jan; 35(1):475-81. PubMed ID: 23943392
[TBL] [Abstract][Full Text] [Related]
7. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
8. P53 codon 72 polymorphism and lung cancer risk: evidence from 27,958 subjects.
Zhou C; Chen H; Wang A
Tumour Biol; 2013 Oct; 34(5):2961-9. PubMed ID: 23715779
[TBL] [Abstract][Full Text] [Related]
9. Myeloperoxidase -463 G/A polymorphism is associated with lung cancer risk: A meta-analysis with 7420 cases and 9132 controls.
Zou S; Pan X; Hua C; Wu M; He B; Chen Z
J Cancer Res Ther; 2018 Jun; 14(Supplement):S282-S287. PubMed ID: 29970677
[TBL] [Abstract][Full Text] [Related]
10. The possible association between the presence of an MPO -463 G > A (rs2333227) polymorphism and cervical cancer risk.
Shi X; Li B; Yuan Y; Chen L; Zhang Y; Yang M; Wang J; Qin D
Pathol Res Pract; 2018 Aug; 214(8):1142-1148. PubMed ID: 29937309
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor (VEGF) -2578C/A and -460C/T gene polymorphisms and lung cancer risk: a meta-analysis involving 11 case-control studies.
Song N; Liu B; Wu J; Zhang R; Duan L; He W; Zhang C
Tumour Biol; 2014 Jan; 35(1):859-70. PubMed ID: 23982876
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population.
Lu W; Xing D; Qi J; Tan W; Miao X; Lin D
Int J Cancer; 2002 Nov; 102(3):275-9. PubMed ID: 12397651
[TBL] [Abstract][Full Text] [Related]
13. Myeloperoxidase -463G>A polymorphism and risk of primary lung cancer in a Korean population.
Park JH; Park JM; Kim EJ; Cha SI; Lee EB; Kim CH; Kam S; Jung TH; Park JY
Cancer Detect Prev; 2006; 30(3):257-61. PubMed ID: 16844322
[TBL] [Abstract][Full Text] [Related]
14. Myeloperoxidase G-463A polymorphism and susceptibility to coronary artery disease: a meta-analysis.
Tang N; Wang Y; Mei Q
Gene; 2013 Jul; 523(2):152-7. PubMed ID: 23583798
[TBL] [Abstract][Full Text] [Related]
15. Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians.
Xu LL; Liu G; Miller DP; Zhou W; Lynch TJ; Wain JC; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1555-9. PubMed ID: 12496043
[TBL] [Abstract][Full Text] [Related]
16. Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies.
Yang WJ; Wang MY; Pan FZ; Shi C; Cen H
World J Surg Oncol; 2017 Aug; 15(1):144. PubMed ID: 28764808
[TBL] [Abstract][Full Text] [Related]
17. Menopausal status modifies breast cancer risk associated with the myeloperoxidase (MPO) G463A polymorphism in Caucasian women: a meta-analysis.
Pabalan N; Jarjanazi H; Sung L; Li H; Ozcelik H
PLoS One; 2012; 7(3):e32389. PubMed ID: 22427832
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase G-463A polymorphism and risk of lung and prostate cancer in a Turkish population.
Arslan S; Pinarbasi H; Silig Y
Mol Med Rep; 2011; 4(1):87-92. PubMed ID: 21461569
[TBL] [Abstract][Full Text] [Related]
19. CCND1 G870A polymorphism interaction with cigarette smoking increases lung cancer risk: meta-analyses based on 5008 cases and 5214 controls.
Duan YZ; Zhang L; Liu CC; Zhu B; Zhuo WL; Chen ZT
Mol Biol Rep; 2013 Jul; 40(7):4625-35. PubMed ID: 23653001
[TBL] [Abstract][Full Text] [Related]
20. Myeloperoxidase -463 (G-->A) polymorphism associated with lower risk of lung cancer.
Kantarci OH; Lesnick TG; Yang P; Meyer RL; Hebrink DD; McMurray CT; Weinshenker BG
Mayo Clin Proc; 2002 Jan; 77(1):17-22. PubMed ID: 11794452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
